Sanders Capital, LLC Astrazeneca PLC Transaction History
Sanders Capital, LLC
- $66.6 Billion
- Q1 2025
A detailed history of Sanders Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sanders Capital, LLC holds 15,068,986 shares of AZN stock, worth $1.07 Billion. This represents 1.66% of its overall portfolio holdings.
Number of Shares
15,068,986
Previous 15,186,692
0.78%
Holding current value
$1.07 Billion
Previous $995 Million
11.31%
% of portfolio
1.66%
Previous 1.46%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
505MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.04 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.88 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.52 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...